Quels sont les états financiers clés de MicroTech Medical (Hangzhou) Co., Ltd. ?
Quels sont les ratios financiers clés pour 02235.HK ?
Comment les revenus de MicroTech Medical (Hangzhou) Co., Ltd. sont-ils répartis par segment ou géographie ?
MicroTech Medical (Hangzhou) Co., Ltd. est-elle rentable ?
MicroTech Medical (Hangzhou) Co., Ltd. a-t-elle des passifs ?
Combien d'actions en circulation MicroTech Medical (Hangzhou) Co., Ltd. a-t-elle ?
Statistiques clés
Clôture préc.
$7.8
Prix d'ouverture
$7.78
Plage de la journée
$7.78 - $7.8
Plage de 52 semaines
$4 - $9.17
Volume
44.5K
Volume moyen
239.8K
BPA (TTM)
-0.07
Rendement en dividend
--
Capitalisation boursière
$1.2B
Qu’est-ce que MICROTECH MED-B ?
MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables. The company is headquartered in Hangzhou, Zhejiang and currently employs 645 full-time employees. The company went IPO on 2021-10-19. The firm's main business is engaged in the manufacture and sale of blood glucose monitoring system (BGMS), continuous glucose monitoring system (CGMS) and insulin pump systems. The firm has the portfolio of products in the field of diabetes monitoring, treatment and management, covering patch insulin pump system, CGMS, closed-loop artificial pancreas system, BGMS products, as well as diabetes digital management software. The firm conducts its businesses in the domestic and overseas markets.